Healthcare provider profile · identity verified

Barbara A Hill, MD

Internal Medicine · SIDNEY, OH · NPI 1932176971

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	403	99
Amlodipine Besylate	Amlodipine Besylate	328	78
Atorvastatin Calcium	Atorvastatin Calcium	317	78
Omeprazole	Omeprazole	244	63
Gabapentin	Gabapentin	242	54
Losartan Potassium	Losartan Potassium	204	53
Sertraline Hcl	Sertraline Hcl	158	51
Lisinopril	Lisinopril	148	44
Famotidine	Famotidine	133	26
Rosuvastatin Calcium	Rosuvastatin Calcium	130	35
Simvastatin	Simvastatin	130	35
Metformin Hcl Er	Metformin Hcl	128	32
Pravastatin Sodium	Pravastatin Sodium	121	31
Pantoprazole Sodium	Pantoprazole Sodium	120	35
Meloxicam	Meloxicam	117	29
Buspirone Hcl	Buspirone Hcl	111	28
Albuterol Sulfate Hfa	Albuterol Sulfate	105	30
Valsartan	Valsartan	101	24
Lorazepam	Lorazepam	100	22
Fluticasone Propionate	Fluticasone Propionate	99	46
Alendronate Sodium	Alendronate Sodium	96	19
Trazodone Hcl	Trazodone Hcl	96	24
Hydrochlorothiazide	Hydrochlorothiazide	95	22
Metoprolol Succinate	Metoprolol Succinate	85	25
Montelukast Sodium	Montelukast Sodium	83	19
Methylprednisolone	Methylprednisolone	79	58
Metformin Hcl	Metformin Hcl	78	21
Furosemide	Furosemide	77	17
Ropinirole Hcl	Ropinirole Hcl	76	17
Citalopram Hbr	Citalopram Hydrobromide	75	20
Duloxetine Hcl	Duloxetine Hcl	75	21
Escitalopram Oxalate	Escitalopram Oxalate	72	17
Glimepiride	Glimepiride	68	19
Potassium Chloride	Potassium Chloride	66	22
Venlafaxine Hcl Er	Venlafaxine Hcl	65	14
Tramadol Hcl	Tramadol Hcl	60	12
Clonazepam	Clonazepam	58	suppressed
Paroxetine Hcl	Paroxetine Hcl	56	12
Hydralazine Hcl	Hydralazine Hcl	52	12
Triamcinolone Acetonide	Triamcinolone Acetonide	52	29
Metoprolol Tartrate	Metoprolol Tartrate	51	13
Cefuroxime	Cefuroxime Axetil	49	39
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Ondansetron Hcl	Ondansetron Hcl	43	12
Synthroid	Levothyroxine Sodium	43	11
Alprazolam	Alprazolam	40	12
Carvedilol	Carvedilol	40	12
Diclofenac Sodium	Diclofenac Sodium	40	20
Bupropion Xl	Bupropion Hcl	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Nystatin	Nystatin	34	19
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Cephalexin	Cephalexin	25	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Eliquis	Apixaban	22	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Chlorzoxazone	Chlorzoxazone	20	suppressed
Colesevelam Hcl	Colesevelam Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Atenolol	Atenolol	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Glipizide	Glipizide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Temazepam	Temazepam	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Diazepam	Diazepam	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lactulose	Lactulose	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Azithromycin	Azithromycin	14	12
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mupirocin	Mupirocin	13	11
Carisoprodol	Carisoprodol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error